Trial of Roflumilast in Asthma Management (TRIM)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anne Dixon, MD
University of Vermont
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama Lung Health Center
Birmingham, Alabama, United States
- University of Arizona
Tucson, Arizona, United States
- Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
- University of Illinois at Chicago, Breathe Chicago Center
Chicago, Illinois, United States
- Mount Sinai Icahn School of Medicine
New York, New York, United States
- Duke University
Durham, North Carolina, United States
- University of Vermont
Colchester, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Aug 2018
- Primary completion
- 30 Jul 2021
- Completion
- 30 Jul 2021
- Last update posted
- 6 Oct 2022
- Registered enrollment
- 38
- Registry id
- NCT03532490
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.